Global Oligonucleotide Therapeutics Market Research Report 2022 - Market Size, Current Insights and Development Trends

Publisher Name :
Date: 01-Dec-2022
No. of pages: 111

The report focuses on the Oligonucleotide Therapeutics market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.

Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Oligonucleotide Therapeutics market.

Major Players in the Oligonucleotide Therapeutics market are:

Merck

Ionis Pharmaceuticals

SomaGenics

Sarepta Therapeutics

miRagen Therapeutics

Gilead

GlaxoSmithKline

Pfizer

Arrowhead Pharmaceuticals

Regulus Therapeutics

ContraVir

PCI Biotech

Alnylam

Biogen

On the basis of types, the Oligonucleotide Therapeutics market is primarily split into:

Antisense/RNAi oligonucleotides

Others

On the basis of applications, the market covers:

Neurological disorders

Cancer

Others

Major Regions or countries covered in this report:

United States

Europe

China

Japan

India

Southeast Asia

Latin America

Middle East and Africa

Others

Years considered for this report:

Historical Years: 2017-2021

Base Year: 2021

Estimated Year: 2022

Forecast Period: 2022-2029

Global Oligonucleotide Therapeutics Market Research Report 2022 - Market Size, Current Insights and Development Trends

Table of Content

1 Oligonucleotide Therapeutics Market Overview
1.1 Product Overview and Scope of Oligonucleotide Therapeutics Market
1.2 Oligonucleotide Therapeutics Market Segment by Type
1.2.1 Global Oligonucleotide Therapeutics Market Sales and CAGR (%) Comparison by Type (2017-2029)
1.3 Global Oligonucleotide Therapeutics Market Segment by Application
1.3.1 Oligonucleotide Therapeutics Market Consumption (Sales) Comparison by Application (2017-2029)
1.4 Global Oligonucleotide Therapeutics Market, Region Wise (2017-2029)
1.5 Global Market Size (Revenue) of Oligonucleotide Therapeutics (2017-2029)
1.5.1 Global Oligonucleotide Therapeutics Market Revenue Status and Outlook (2017-2029)
1.5.2 Global Oligonucleotide Therapeutics Market Sales Status and Outlook (2017-2029)
1.6 Influence of Regional Conflicts on the Oligonucleotide Therapeutics Industry
1.7 Impact of Carbon Neutrality on the Oligonucleotide Therapeutics Industry

2 Oligonucleotide Therapeutics Market Upstream and Downstream Analysis
2.1 Oligonucleotide Therapeutics Industrial Chain Analysis
2.2 Key Raw Materials Suppliers and Price Analysis
2.3 Key Raw Materials Supply and Demand Analysis
2.4 Market Concentration Rate of Raw Materials
2.5 Manufacturing Process Analysis
2.6 Manufacturing Cost Structure Analysis
2.6.1 Labor Cost Analysis
2.6.2 Energy Costs Analysis
2.6.3 R&D Costs Analysis
2.7 Major Downstream Buyers of Oligonucleotide Therapeutics Analysis
2.8 Impact of COVID-19 on the Industry Upstream and Downstream

3 Players Profiles
3.1 Merck
3.1.1 Merck Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Product Profiles, Application and Specification
3.1.3 Oligonucleotide Therapeutics Market Performance (2017-2022)
3.1.4 Business Overview
3.2 Ionis Pharmaceuticals
3.2.1 Ionis Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Product Profiles, Application and Specification
3.2.3 Oligonucleotide Therapeutics Market Performance (2017-2022)
3.2.4 Business Overview
3.3 SomaGenics
3.3.1 SomaGenics Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Product Profiles, Application and Specification
3.3.3 Oligonucleotide Therapeutics Market Performance (2017-2022)
3.3.4 Business Overview
3.4 Sarepta Therapeutics
3.4.1 Sarepta Therapeutics Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Product Profiles, Application and Specification
3.4.3 Oligonucleotide Therapeutics Market Performance (2017-2022)
3.4.4 Business Overview
3.5 miRagen Therapeutics
3.5.1 miRagen Therapeutics Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Product Profiles, Application and Specification
3.5.3 Oligonucleotide Therapeutics Market Performance (2017-2022)
3.5.4 Business Overview
3.6 Gilead
3.6.1 Gilead Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Product Profiles, Application and Specification
3.6.3 Oligonucleotide Therapeutics Market Performance (2017-2022)
3.6.4 Business Overview
3.7 GlaxoSmithKline
3.7.1 GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Product Profiles, Application and Specification
3.7.3 Oligonucleotide Therapeutics Market Performance (2017-2022)
3.7.4 Business Overview
3.8 Pfizer
3.8.1 Pfizer Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Product Profiles, Application and Specification
3.8.3 Oligonucleotide Therapeutics Market Performance (2017-2022)
3.8.4 Business Overview
3.9 Arrowhead Pharmaceuticals
3.9.1 Arrowhead Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Product Profiles, Application and Specification
3.9.3 Oligonucleotide Therapeutics Market Performance (2017-2022)
3.9.4 Business Overview
3.10 Regulus Therapeutics
3.10.1 Regulus Therapeutics Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Product Profiles, Application and Specification
3.10.3 Oligonucleotide Therapeutics Market Performance (2017-2022)
3.10.4 Business Overview
3.11 ContraVir
3.11.1 ContraVir Basic Information, Manufacturing Base, Sales Area and Competitors
3.11.2 Product Profiles, Application and Specification
3.11.3 Oligonucleotide Therapeutics Market Performance (2017-2022)
3.11.4 Business Overview
3.12 PCI Biotech
3.12.1 PCI Biotech Basic Information, Manufacturing Base, Sales Area and Competitors
3.12.2 Product Profiles, Application and Specification
3.12.3 Oligonucleotide Therapeutics Market Performance (2017-2022)
3.12.4 Business Overview
3.13 Alnylam
3.13.1 Alnylam Basic Information, Manufacturing Base, Sales Area and Competitors
3.13.2 Product Profiles, Application and Specification
3.13.3 Oligonucleotide Therapeutics Market Performance (2017-2022)
3.13.4 Business Overview
3.14 Biogen
3.14.1 Biogen Basic Information, Manufacturing Base, Sales Area and Competitors
3.14.2 Product Profiles, Application and Specification
3.14.3 Oligonucleotide Therapeutics Market Performance (2017-2022)
3.14.4 Business Overview

4 Global Oligonucleotide Therapeutics Market Landscape by Player
4.1 Global Oligonucleotide Therapeutics Sales and Share by Player (2017-2022)
4.2 Global Oligonucleotide Therapeutics Revenue and Market Share by Player (2017-2022)
4.3 Global Oligonucleotide Therapeutics Average Price by Player (2017-2022)
4.4 Global Oligonucleotide Therapeutics Gross Margin by Player (2017-2022)
4.5 Oligonucleotide Therapeutics Market Competitive Situation and Trends
4.5.1 Oligonucleotide Therapeutics Market Concentration Rate
4.5.2 Oligonucleotide Therapeutics Market Share of Top 3 and Top 6 Players
4.5.3 Mergers & Acquisitions, Expansion

5 Global Oligonucleotide Therapeutics Sales, Revenue, Price Trend by Type
5.1 Global Oligonucleotide Therapeutics Sales and Market Share by Type (2017-2022)
5.2 Global Oligonucleotide Therapeutics Revenue and Market Share by Type (2017-2022)
5.3 Global Oligonucleotide Therapeutics Price by Type (2017-2022)
5.4 Global Oligonucleotide Therapeutics Sales, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Oligonucleotide Therapeutics Sales, Revenue and Growth Rate of Antisense/RNAi oligonucleotides (2017-2022)
5.4.2 Global Oligonucleotide Therapeutics Sales, Revenue and Growth Rate of Others (2017-2022)

6 Global Oligonucleotide Therapeutics Market Analysis by Application
6.1 Global Oligonucleotide Therapeutics Consumption and Market Share by Application (2017-2022)
6.2 Global Oligonucleotide Therapeutics Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Oligonucleotide Therapeutics Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Oligonucleotide Therapeutics Consumption and Growth Rate of Neurological disorders (2017-2022)
6.3.2 Global Oligonucleotide Therapeutics Consumption and Growth Rate of Cancer (2017-2022)
6.3.3 Global Oligonucleotide Therapeutics Consumption and Growth Rate of Others (2017-2022)

7 Global Oligonucleotide Therapeutics Sales and Revenue Region Wise (2017-2022)
7.1 Global Oligonucleotide Therapeutics Sales and Market Share, Region Wise (2017-2022)
7.2 Global Oligonucleotide Therapeutics Revenue and Market Share, Region Wise (2017-2022)
7.3 Global Oligonucleotide Therapeutics Sales, Revenue, Price and Gross Margin (2017-2022)
7.4 United States Oligonucleotide Therapeutics Sales, Revenue, Price and Gross Margin (2017-2022)
7.5 Europe Oligonucleotide Therapeutics Sales, Revenue, Price and Gross Margin (2017-2022)
7.6 China Oligonucleotide Therapeutics Sales, Revenue, Price and Gross Margin (2017-2022)
7.7 Japan Oligonucleotide Therapeutics Sales, Revenue, Price and Gross Margin (2017-2022)
7.8 India Oligonucleotide Therapeutics Sales, Revenue, Price and Gross Margin (2017-2022)
7.9 Southeast Asia Oligonucleotide Therapeutics Sales, Revenue, Price and Gross Margin (2017-2022)
7.10 Latin America Oligonucleotide Therapeutics Sales, Revenue, Price and Gross Margin (2017-2022)
7.11 Middle East and Africa Oligonucleotide Therapeutics Sales, Revenue, Price and Gross Margin (2017-2022)

8 Global Oligonucleotide Therapeutics Market Forecast (2022-2029)
8.1 Global Oligonucleotide Therapeutics Sales, Revenue Forecast (2022-2029)
8.1.1 Global Oligonucleotide Therapeutics Sales and Growth Rate Forecast (2022-2029)
8.1.2 Global Oligonucleotide Therapeutics Revenue and Growth Rate Forecast (2022-2029)
8.1.3 Global Oligonucleotide Therapeutics Price and Trend Forecast (2022-2029)
8.2 Global Oligonucleotide Therapeutics Sales and Revenue Forecast, Region Wise (2022-2029)
8.2.1 United States Oligonucleotide Therapeutics Sales and Revenue Forecast (2022-2029)
8.2.2 Europe Oligonucleotide Therapeutics Sales and Revenue Forecast (2022-2029)
8.2.3 China Oligonucleotide Therapeutics Sales and Revenue Forecast (2022-2029)
8.2.4 Japan Oligonucleotide Therapeutics Sales and Revenue Forecast (2022-2029)
8.2.5 India Oligonucleotide Therapeutics Sales and Revenue Forecast (2022-2029)
8.2.6 Southeast Asia Oligonucleotide Therapeutics Sales and Revenue Forecast (2022-2029)
8.2.7 Latin America Oligonucleotide Therapeutics Sales and Revenue Forecast (2022-2029)
8.2.8 Middle East and Africa Oligonucleotide Therapeutics Sales and Revenue Forecast (2022-2029)
8.3 Global Oligonucleotide Therapeutics Sales, Revenue and Price Forecast by Type (2022-2029)
8.3.1 Global Oligonucleotide Therapeutics Revenue and Growth Rate of Antisense/RNAi oligonucleotides (2022-2029)
8.3.2 Global Oligonucleotide Therapeutics Revenue and Growth Rate of Others (2022-2029)
8.4 Global Oligonucleotide Therapeutics Consumption Forecast by Application (2022-2029)
8.4.1 Global Oligonucleotide Therapeutics Consumption Value and Growth Rate of Neurological disorders (2022-2029)
8.4.2 Global Oligonucleotide Therapeutics Consumption Value and Growth Rate of Cancer (2022-2029)
8.4.3 Global Oligonucleotide Therapeutics Consumption Value and Growth Rate of Others (2022-2029)
8.5 Oligonucleotide Therapeutics Market Forecast Under COVID-19

9 Industry Outlook
9.1 Oligonucleotide Therapeutics Market Drivers Analysis
9.2 Oligonucleotide Therapeutics Market Restraints and Challenges
9.3 Oligonucleotide Therapeutics Market Opportunities Analysis
9.4 Emerging Market Trends
9.5 Oligonucleotide Therapeutics Industry Technology Status and Trends
9.6 News of Product Release
9.7 Consumer Preference Analysis
9.8 Oligonucleotide Therapeutics Industry Development Trends under COVID-19 Outbreak
9.8.1 Global COVID-19 Status Overview
9.8.2 Influence of COVID-19 Outbreak on Oligonucleotide Therapeutics Industry Development

10 Research Findings and Conclusion

11 Appendix
11.1 Methodology
11.2 Research Data Source
  • Global Healthcare Workforce Management System Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 86
    Workforce management is an institutional process that maximizes performance levels and competency for an organization. The process includes all The activities needed to maintain a productive workforce, such as field service management, human resource management, performance and training management, data collection, recruiting, budgeting, forecasting, scheduling and analytics. Workforce management provides a common set of performance-based tools and software to support corporate mana......
  • Global Life Science Analytics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Life Science Analytics market size was valued at US$ 23410 million in 2023. With growing demand in downstream market, the Life Science Analytics is forecast to a readjusted size of US$ 47330 million by 2030 with a CAGR of 10.6% during review period. The research report highlights the growth potential of the global Life Science Analytics market. Life Science Analytics are expected to show stable growth in the future market. Ho......
  • Global Patient Engagement Solutions Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116
    According to our LPI (LP Information) latest study, the global Patient Engagement Solutions market size was valued at US$ 14090 million in 2023. With growing demand in downstream market, the Patient Engagement Solutions is forecast to a readjusted size of US$ 53040 million by 2030 with a CAGR of 20.9% during review period. The research report highlights the growth potential of the global Patient Engagement Solutions market. Patient Engagement Solutions are expected to show stable growth ......
  • Global Operating Room Management Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 117
    According to our LPI (LP Information) latest study, the global Operating Room Management market size was valued at US$ 4314.6 million in 2023. With growing demand in downstream market, the Operating Room Management is forecast to a readjusted size of US$ 6494.7 million by 2030 with a CAGR of 6.0% during review period. The research report highlights the growth potential of the global Operating Room Management market. Operating Room Management are expected to show stable growth in the futu......
  • Global Healthcare Supply Chain Managements Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 112
    According to our LPI (LP Information) latest study, the global Healthcare Supply Chain Managements market size was valued at US$ 2151.2 million in 2023. With growing demand in downstream market, the Healthcare Supply Chain Managements is forecast to a readjusted size of US$ 4098.9 million by 2030 with a CAGR of 9.6% during review period. The research report highlights the growth potential of the global Healthcare Supply Chain Managements market. Healthcare Supply Chain Managements are ex......
  • Global Healthcare Workforce Management System Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 108
    According to our LPI (LP Information) latest study, the global Healthcare Workforce Management System market size was valued at US$ 1543.3 million in 2023. With growing demand in downstream market, the Healthcare Workforce Management System is forecast to a readjusted size of US$ 3331.2 million by 2030 with a CAGR of 11.6% during review period. The research report highlights the growth potential of the global Healthcare Workforce Management System market. Healthcare Workforce Management ......
  • Global Behavioral Health Software Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158
    According to our LPI (LP Information) latest study, the global Behavioral Health Software market size was valued at US$ 1641 million in 2023. With growing demand in downstream market, the Behavioral Health Software is forecast to a readjusted size of US$ 3274.7 million by 2030 with a CAGR of 10.4% during review period. The research report highlights the growth potential of the global Behavioral Health Software market. Behavioral Health Software are expected to show stable growth in the f......
  • Global Long-term Care Software Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Long-term Care Software market size was valued at US$ 1339.2 million in 2023. With growing demand in downstream market, the Long-term Care Software is forecast to a readjusted size of US$ 3460.2 million by 2030 with a CAGR of 14.5% during review period. The research report highlights the growth potential of the global Long-term Care Software market. Long-term Care Software are expected to show stable growth in the future mark......
  • Global Healthcare RCM Outsourcing Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 110
    According to our LPI (LP Information) latest study, the global Healthcare RCM Outsourcing market size was valued at US$ 19580 million in 2023. With growing demand in downstream market, the Healthcare RCM Outsourcing is forecast to a readjusted size of US$ 40390 million by 2030 with a CAGR of 10.9% during review period. The research report highlights the growth potential of the global Healthcare RCM Outsourcing market. Healthcare RCM Outsourcing are expected to show stable growth in the f......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs